Genetic factors may underlie susceptibility to serious adverse drug reactions (SADRs). Here, the authors discuss three SADRs — liver injury, myotoxicity and long QT syndrome — and consider the challenges that need to be overcome to identify predisposing genotypes, which might improve patient management.
- Russell A. Wilke
- Debbie W. Lin
- Ronald M. Krauss
